Wis. Admin. Code Controlled Substances Board CSB 2 app Appendix - Appendix

  1. § CSB 2.01 - Addition of methaqualone to schedule II
  2. § CSB 2.02 - Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III
  3. § CSB 2.03 - Addition of fenfluramine to schedule IV
  4. § CSB 2.04 - Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III
  5. § CSB 2.05 - Addition of drotebanol to schedule I
  6. § CSB 2.06 - Addition of pentazocine to schedule III
  7. § CSB 2.07 - Transfer of hydrochloride form of etorphine from schedule I to schedule II
  8. § CSB 2.08 - Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV
  9. § CSB 2.09 - Additions to schedules IV and I
  10. § CSB 2.10 - Addition of propiram to schedule I
  11. § CSB 2.11 - Renumbering and addition to schedule IV of diethylpropion and phentermine
  12. § CSB 2.13 - Addition of dextropropoxyphene to schedule IV
  13. § CSB 2.14 - Addition of prazepam to schedule IV
  14. § CSB 2.15 - Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV
  15. § CSB 2.16 - Transfer of sufentanil from schedule I to schedule II
  16. § CSB 2.17 - Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II
  17. § CSB 2.18 - Addition of 3,4-methylenedioxymethamphetamine to schedule I
  18. § CSB 2.19 - Additions, deletions and transfers to statutory schedules
  19. § CSB 2.20 - Addition of beta-hydroxy-3-methylfentanyl to schedule I
  20. § CSB 2.21 - Additions, deletions, corrections, transfers, and amendments to drug schedules
  21. § CSB 2.22 - Additions to drug schedules
  22. § CSB 2.23 - Additions and amendments to drug schedules
  23. § CSB 2.24 - Addition of butorphanol to schedule IV
  24. § CSB 2.25 - Addition of remifentanil to schedule II; transfer of dronabinol from schedule II to schedule III; addition of fenproporex, modafinil, sibutramine, zaleplon and zolpidem to schedule IV; spelling correction of carfentanil
  25. § CSB 2.26 - Addition of dihydroetorphine to schedule II
  26. § CSB 2.28 - Addition of dichloralphenazone to schedule IV
  27. § CSB 2.29 - Transfer of buprenorphine from schedule V to schedule III
  28. § CSB 2.30 - Addition of gamma-hydroxybutyric acid to schedule III
  29. § CSB 2.31 - Addition of 2,5 dimethoxy-4-(n)- propylthiophenethylamine (2C-T-7) to schedule I
  30. § CSB 2.32 - Addition of N- benzylpiperazine (BZP) to schedule I
  31. § CSB 2.33 - Addition of alpha-methyltryptamine (AMT) to schedule I
  32. § CSB 2.34 - Addition of 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DIPT)
  33. § CSB 2.35 - Addition of lisdexamfetamine to schedule II
  34. § CSB 2.36 - Addition of tramadol to schedule IV
  35. § CSB 2.37 - Rescheduling of hydrocodone combination products
  36. § CSB 2.38 - Addition of suvorexant to schedule IV
  37. § CSB 2.39 - Exclusion of naloxegol
  38. § CSB 2.40 - Exclusion of [123I] ioflupan
  39. § CSB 2.41 - Scheduling of beta-hydroxythiofentanyl and butyryl fentanyl
  40. § CSB 2.42 - Scheduling of furanyl fentanyl
  41. § CSB 2.43 - Addition of brivaracetam to schedule V
  42. § CSB 2.44 - Addition of thiafentanil to schedule II
  43. § CSB 2.45 - Addition of AB-FUBINACA and ADB-PINACA to schedule I
  44. § CSB 2.46 - Addition of acetyl fentanyl to schedule I
  45. § CSB 2.47 - Addition of AH-7921 to schedule I
  46. § CSB 2.48 - Addition of eluxadoline to schedule IV
  47. § CSB 2.49 - Addition of U-47700 to schedule I
  48. § CSB 2.50 - Addition of AB-CHMINACA, AB-PINACA and THJ-2201 to schedule I
  49. § CSB 2.51 - Addition of MAB-CHMINACA to schedule I
  50. § CSB 2.52 - Addition of 4-MePPP and a-PBP to schedule I
  51. § CSB 2.53 - Scheduling of acryl fentanyl
  52. § CSB 2.54 - Addition of oral solutions containing dronabinol to schedule II
  53. § CSB 2.55 - Addition of 5F-ADB, 5F-AMB, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA to schedule I
  54. § CSB 2.56 - Addition of 4-fluoroisobutyryl fentanyl to schedule I
  55. § CSB 2.57 - Scheduling of cyclopropyl fentanyl
  56. § CSB 2.58 - Exclusion of naldemedine
  57. § CSB 2.59 - Addition of ortho-fluorofentanyl to schedule I
  58. § CSB 2.60 - Addition of FUB-AMB to schedule I
  59. § CSB 2.61 - Addition of MT-45 to schedule I
  60. § CSB 2.62 - Addition of para-chloroisobutyryl fentanyl to schedule I
  61. § CSB 2.63 - Addition of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA to schedule I
  62. § CSB 2.64 - Addition of N-Ethylpentylone to schedule I
  63. § CSB 2.65 - Addition of approved cannabidiol drugs to schedule V
  64. § CSB 2.66 - Addition of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 to schedule I
  65. § CSB 2.67 - Addition of Brexanolone and Solriamfetol to schedule IV
  66. § CSB 2.68 - Addition of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8 and 4-chloro-a-PVP to schedule I
  67. § CSB 2.69 - Addition of Noroxymorphone to schedule II
  68. § CSB 2.70 - Scheduling 4F-MDMB-BINACA and MMB-FUBICA
  69. § CSB 2.71 - Addition of lasmiditan to schedule V
  70. § CSB 2.72 - Scheduling of isotonitazene and 1P-LSD
  71. § CSB 2.73 - Addition of cenobamate to schedule V
  72. § CSB 2.74 - Addition of Lemborexant to schedule IV
  73. § CSB 2.75 - Exclusion of approved cannabidiol drugs from schedule I
  74. § CSB 2.76 - Addition of norfentanyl to schedule II
  75. § CSB 2.77 - Scheduling of flualprazolam
  76. § CSB 2.78 - Addition of crotonyl fentanyl to schedule I
  77. § CSB 2.79 - Addition of remimazolam to schedule IV
  78. § CSB 2.80 - Scheduling of oliceridine
  79. § CSB 2.81 - Addition of brorphine to schedule I
  80. § CSB 2.82 - Addition of Serdexmethylphenidate to schedule IV
  81. § CSB 2.83 - Addition of ten (10) fentanyl-related substances to schedule I
  82. § CSB 2.84 - Addition of alfaxalone to schedule IV
  83. § CSB 2.85 - Excluding 6-beta-naltrexol from schedule II
  84. § CSB 2.86 - Addition of fospropofol to schedule IV
  85. § CSB 2.87 - Addition of embutramide to schedule III
  86. § CSB 2.88 - Addition of lacosamide to schedule V
  87. § CSB 2.89 - Addition of perampanel to schedule III
  88. § CSB 2.90 - Transfer of 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile, immediate precursors to phencyclidine, also known as PCP, from Schedule I to schedule II
  89. § CSB 2.91 - Addition of 4,4'-Dimethylaminorex to schedule I
  90. § CSB 2.92 - Addition of thirty-eight (38) Anabolic Steroids to schedule III
  91. § CSB 2.93 - Addition of Daridorexant to schedule IV
  92. § CSB 2.94 - Addition of seven (7) synthetic benzimidazole-opioid substances to schedule I
  93. § CSB 2.95 - Addition of Ganaxolone to schedule V
  94. § CSB 2.96 - Addition of Amineptine to schedule I
  95. § CSB 2.97 - Addition of Zipeprol to schedule I
  96. § CSB 2.98 - xcluding [[18]F] FP-CIT from schedule II
  97. § CSB 2.99 - Addition of Mesocarb to schedule I

Notes

Wis. Admin. Code Controlled Substances Board CSB 2 app Appendix

This Appendix contains actions of the Controlled Substances Board that were made prior to April 3, 2023, which were numbered ss. CSB 2.01 to 2.99.

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.

No prior version found.